Skip to Main Content

Paper Details

Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2.
EuroIntervention
5
2022
ARC, HBR, Patients, atrial fibrillation, cerebrovascular, coronary artery disease, diabetes, patients
Author NameAffiliation
Christian HengstenbergMedical University of Vienna
  • 1 - 1

Datasets

Release 1.2